by Vora Corporate Finance | Oct 26, 2024 | Insights, Merger & Acquisitions
Transaction: Mankind Pharma Limited is to acquire 100% stake in Bharat Serums and Vaccines Limited (BSV) from PE fund Advent International for an EV of Rs. 13,630 Crores. The transaction was done at EV/Ebitda multiple of around 22x to 23x. The deal will be through...
by Vora Corporate Finance | Oct 26, 2024 | Insights
The BSE Sensex closed at 81,455 up by 3.07% and the Nifty 50 closed at 24,857 up by 3.53% in July 2024 led as the market’s focus shifted to the Federal Reserve’s rate decision and commentary on monetary policy despite the volatility experienced after the budget on the...
by Vora Corporate Finance | Oct 26, 2024 | Insights
Union Budget 2024-25: Finance Minister (Nirmala Sitharaman) presented the first budget of BJP led NDA government’s third term and as per expectation continued the sustainable economic development goals in pursuit of ‘Viksit Bharat’. It focused on nine priorities:...
by Vora Corporate Finance | Jul 9, 2024 | Insights
World Environment Day – 5th June, 2024. All over the world, ecosystems are threatened, this is why World Environment Day 2024 focuses on land restoration, halting desertification and building drought resilience under the slogan “Our land. Our future. We are...
by Vora Corporate Finance | Jul 8, 2024 | Insights, Private Equity & IPO
Transaction: Morgan Stanley PE fund, invested INR 500 Crores for a minority stake of 23% stake in Hyderabad Institute of Oncology Private Limited (Omega Hospitals), valuing the hospital chain at more than Rs. 2100 Crores. It will support the ambitious plan of Omega...
